AXGN vs NDAQ · rev $131.2M vs P/E 41, rev $2.53B
Axogen Inc (AXGN) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Axogen Inc (AXGN) is a medical devices company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported AXGN revenue for 2026-06-30 was $131.2M. Net income was -$21.1M. AXGN currently screens at market cap $497.8M.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
AXGN currently screens at market cap $497.8M. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the AXGN and NDAQ stock pages for the full models.
Not investment advice.